Patents Assigned to Aidan, Inc.
  • Patent number: 7749495
    Abstract: The invention relates to inducing an immune response toward tumor associated antigens and in particular to the administration of high molecular weight isolates of autologous urine either alone, with adjuvants, or with antigen presenting cells. The antigen presenting cells have been cocultured with isolates of autologous urine. The invention can also be used to treat cachexia in cancer or AIDS patients.
    Type: Grant
    Filed: May 23, 2008
    Date of Patent: July 6, 2010
    Assignee: Aidan, Inc.
    Inventor: Neil H. Riordan